Sample Name
Sample Code
Sample Name
Sample Code
Sample Name
Sample Code
4
SHANGHAI PECHEM
00338
5
SINOPEC CORP
00386
| (Q2)Jan 31, 2026 | (Q1)Oct 31, 2025 | (FY)Jul 31, 2025 | (Q4)Jul 31, 2025 | (Q3)Apr 30, 2025 | (Q2)Jan 31, 2025 | (Q1)Oct 31, 2024 | (FY)Jul 31, 2024 | (Q4)Jul 31, 2024 | (Q3)Apr 30, 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Operating Cash Flow (Indirect Method) | ||||||||||
| Cash flow from continuing operating activities | 63.85%-116.47K | 47.86%-117.95K | -40.90%-781.34K | 9.18%-119K | 0.33%-113.97K | -52.18%-322.17K | -132.12%-226.2K | 9.07%-554.52K | -44.75%-131.03K | 9.44%-114.34K |
| Net income from continuing operations | 21.62%-213.54K | -1.23%-370.02K | 26.82%-955.39K | 223.73%667.04K | -446.91%-984.47K | -3.84%-272.43K | -12.77%-365.53K | 32.19%-1.31M | -115.47%-539.13K | 47.03%-180.01K |
| Depreciation and amortization | 0.01%13.72K | -0.01%13.71K | -0.62%54.86K | 0.01%13.72K | 0.00%13.71K | -0.01%13.71K | -2.44%13.72K | -3.08%55.2K | -3.69%13.71K | -3.69%13.71K |
| Asset impairment expenditure | ---- | ---- | --0 | ---- | ---- | ---- | ---- | 993.67%350.85K | --350.85K | ---- |
| Remuneration paid in stock | --65.97K | --245.83K | --0 | --0 | --0 | --0 | --0 | -69.16%369.64K | -78.47%12.6K | -73.17%40.88K |
| Other non cashItems | -32.01%2.65K | -96.72%2.97K | 419.36%101.31K | -18,813.38%-836.11K | 17,665.92%842.99K | -22.37%3.89K | 1,615.33%90.54K | -17.32%19.51K | -19.23%4.47K | -17.91%4.75K |
| Change In working capital | 121.89%14.74K | -129.77%-10.44K | 140.56%17.89K | 37.35%36.36K | 118.12%13.79K | -6.35%-67.34K | 358.22%35.08K | -1,085.37%-44.11K | -67.48%26.47K | -84.64%6.32K |
| -Change in receivables | 88.68%-1.95K | -88.64%3.77K | 175.16%43.22K | 95.30%-2.63K | 204.38%29.91K | -76.43%-17.2K | 2,106.90%33.13K | -2,976.46%-57.5K | -9,421.17%-55.93K | 26.25%9.83K |
| -Change in prepaid assets | 1,437.68%16.28K | -149.37%-9.16K | 133.48%4.19K | -445.39%-8.16K | 54.16%14.96K | 219.26%1.06K | 81.48%-3.67K | -57.91%-12.51K | -105.68%-1.5K | -79.38%9.71K |
| -Change in payables and accrued expense | 100.79%403 | -189.83%-5.05K | -213.94%-29.52K | -43.80%47.15K | -135.29%-31.08K | 2.81%-51.2K | -28.91%5.62K | 81.56%25.91K | 53.98%83.9K | 3.41%-13.21K |
| Cash from discontinued investing activities | ||||||||||
| Operating cash flow | 63.85%-116.47K | 47.86%-117.95K | -40.90%-781.34K | 9.18%-119K | 0.33%-113.97K | -52.18%-322.17K | -132.12%-226.2K | 9.07%-554.52K | -44.75%-131.03K | 9.44%-114.34K |
| Investing cash flow | ||||||||||
| Cash flow from continuing investing activities | 78.46%-24.78K | 13.70%-86.5K | -126.46%-215.23K | 0 | 0 | -1,468.04%-115K | -27.32%-100.23K | 87.15%-95.04K | 96.70%-8.99K | 0 |
| Net PPE purchase and sale | 78.46%-24.78K | 13.70%-86.5K | -131.57%-215.23K | --0 | --0 | -1,468.04%-115K | -30.81%-100.23K | 86.85%-92.94K | 96.70%-8.99K | --0 |
| Net other investing changes | ---- | ---- | ---- | ---- | ---- | ---- | ---- | 93.58%-2.1K | --0 | --0 |
| Cash from discontinued investing activities | ||||||||||
| Investing cash flow | 78.46%-24.78K | 13.70%-86.5K | -126.46%-215.23K | --0 | --0 | -1,468.04%-115K | -27.32%-100.23K | 87.15%-95.04K | 96.70%-8.99K | --0 |
| Financing cash flow | ||||||||||
| Cash flow from continuing financing activities | 1,871.52%303.76K | 337.27%40.36K | -160.61%-68.45K | -110.48%-17.15K | -1.23%-17.15K | -1.23%-17.15K | -1.24%-17.01K | -96.50%112.94K | 1,077.99%163.62K | -1.25%-16.94K |
| Net issuance payments of debt | -1.21%-17.36K | -1.23%-17.22K | -1.23%-68.45K | -1.23%-17.15K | -1.23%-17.15K | -1.23%-17.15K | -1.24%-17.01K | -1.25%-67.62K | -1.24%-16.94K | -1.25%-16.94K |
| Net common stock issuance | ---- | ---- | --0 | ---- | ---- | ---- | ---- | -93.57%225K | --225K | ---- |
| Net other financing activities | ---167.32K | --57.57K | ---- | ---- | ---- | ---- | ---- | 78.55%-44.44K | ---- | ---- |
| Cash from discontinued financing activities | ||||||||||
| Financing cash flow | 1,871.52%303.76K | 337.27%40.36K | -160.61%-68.45K | -110.48%-17.15K | -1.23%-17.15K | -1.23%-17.15K | -1.24%-17.01K | -96.50%112.94K | 1,077.99%163.62K | -1.25%-16.94K |
| Net cash flow | ||||||||||
| Beginning cash position | -79.13%233.54K | -72.81%397.63K | -26.84%1.46M | -62.91%533.78K | -57.66%664.89K | -38.04%1.12M | -26.84%1.46M | 1,530.32%2M | -39.51%1.44M | -44.23%1.57M |
| Current changes in cash | 135.77%162.52K | 52.22%-164.09K | -98.47%-1.07M | -676.84%-136.15K | 0.12%-131.12K | -92.53%-454.31K | -77.98%-343.44K | -128.59%-536.61K | 106.22%23.6K | 69.97%-131.28K |
| End cash Position | -40.43%396.06K | -79.13%233.54K | -72.81%397.63K | -72.81%397.63K | -62.91%533.78K | -57.66%664.89K | -38.04%1.12M | -26.84%1.46M | -26.84%1.46M | -39.51%1.44M |
| Free cash from | 67.69%-141.24K | 37.37%-204.44K | -53.92%-996.56K | 15.01%-119K | 0.33%-113.97K | -99.59%-437.17K | -87.52%-326.43K | 50.83%-647.46K | 61.41%-140.02K | 72.80%-114.34K |
| Accounting Standards | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP |
| Audit Opinions | -- | -- | Unqualified Opinion with Explanatory Notes | -- | -- | -- | -- | Unqualified Opinion with Explanatory Notes | -- | -- |
FY: Financial Year. Refers to the 10-K file disclosed by the listed company to the SEC.
Q: Quarter. Refers to the 10-Q file disclosed by the listed company to the SEC. Q1, Q2, Q3, and Q4 are quarterly reports each with a span of 3 months; Q6 and Q9 are cumulative reports, with Q6 including 6 months and Q9 9 months.